Skip to main content
. Author manuscript; available in PMC: 2018 Oct 31.
Published in final edited form as: J Psychiatr Pract. 2014 Nov;20(6):438–447. doi: 10.1097/01.pra.0000456592.20622.45

Appendix 1.

Appendix 1. Psychotropic medications with pediatric approval according to the 2007–2010 FDA drug labels

Generic
name
Trade
name
Approved
indication
Age Generic
name
Trade
name
Approved
indication
Age
Amphetamines,
mixed salts
Adderall ADHD 6+ Imipramine Tofranil Enuresis 6+
             
        Lisdexamfetamine Vyvanse ADHD 6+
Aripiprazole Abilify Autism* 6+        
    (irritability)   Methamphetamine Desoxyn ADHD 12+
    Bipolar 10+ Methylphenidate Concerta ADHD 6+
    (mania)     Daytrana ADHD 6+
    Schizophrenia 13+   Methylin ADHD 6+
          Ritalin ADHD 6+
Atomoxetine Strattera ADHD 6+        
Chlorpromazine Thorazine Behavioral 12-Jan Methylphenidate Metadate CD ADHD 6+
    problems   HCl      
Clomipramine Anafranil OCD 10+ Olanzapine Zyprexa Bipolar 13+
            (mania)*  
Desmopressin
acetate
Desmopressin Enuresis 6+     Schizophrenia* 13+
acetate            
        Pimozide Orap Tourette’s 12+
Dexmethylphenidate Focalin ADHD 6+     syndrome  
Dextroamphetamine Dextrostat ADHD 6+ Quetiapine Seroquel Bipolar* 10+
            (mania)  
Dextroamphetamine
sulphate
Dexedrine ADHD 6+     Schizophrenia* 13+
             
        Risperidone Risperdal Autism 5+
Escitalopram Lexapro MDD* 12+     (irritability)  
Fluoxetine Prozac MDD 7+     Bipolar 10+
    OCD 8+     (mania)  
            Schizophrenia 13+
Fluvoxamine Luvox OCD 8+        
        Sertraline Zoloft OCD 6+
Guanfacine Intuniv ADHD* 6+        
Haloperidol Haldol Behavioral 12-Mar
    problems  
    Hyperactivity 12-Mar
    Tourette’s 12-Mar
    syndrome      
*

Medication received FDA approval for this indication after July 2008.

ADHD: attention-deficit/hyperactivity disorder

MDD: major depressive disorder syndrome

OCD: obsessive-compulsive disorder